Here's What Key Metrics Tell Us About Steris (STE) Q2 Earnings

Core Insights - Steris reported revenue of $1.46 billion for the quarter ended September 2025, reflecting a year-over-year increase of 9.9% and surpassing the Zacks Consensus Estimate of $1.43 billion by 2.31% [1] - The company's EPS for the quarter was $2.47, an increase from $2.14 in the same quarter last year, also exceeding the consensus estimate of $2.38 by 3.78% [1] Revenue Performance - Healthcare revenues reached $1.03 billion, exceeding the average estimate of $1.01 billion by analysts, marking a 9.5% increase year-over-year [3] - Healthcare Products - Consumables generated $374.2 million, surpassing the estimated $357.5 million, with a year-over-year growth of 9.5% [3] - Healthcare Products - Capital Equipment reported $259.4 million, slightly below the average estimate of $268.96 million, but still showing a 3.9% increase year-over-year [3] - Healthcare Products - Service revenues were $400.1 million, exceeding the estimate of $374.76 million, reflecting a significant year-over-year increase of 13.4% [3] - Life Sciences revenues totaled $145 million, surpassing the estimated $137.24 million, with a year-over-year growth of 13.3% [3] - Applied Sterilization Technologies (AST) revenues were $281.5 million, slightly above the average estimate of $281.02 million, representing a 9.7% year-over-year increase [3] - Life Sciences - Service revenues reached $35.8 million, below the estimate of $36.79 million, but still showing a 9.1% increase year-over-year [3] - Life Sciences - Capital Equipment generated $31.9 million, exceeding the estimate of $27.85 million, with a notable year-over-year growth of 38.6% [3] - Life Sciences - Consumables reported $77.2 million, surpassing the estimated $71.75 million, reflecting a 7% increase year-over-year [3] Operating Income - Operating income for Healthcare was $259.5 million, exceeding the average estimate of $239.46 million [3] - Corporate and Other reported an operating loss of $109.9 million, slightly worse than the average estimate of $-106.78 million [3] - Operating income for Applied Sterilization Technologies (AST) was $127.6 million, below the average estimate of $132.54 million [3]